Kalaris Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Kalaris Therapeutics (KLRS) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Kalaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kalaris Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kalaris Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $30k | 5.3k | 5.78 |
| 2025-06-30 | $11k | 4.1k | 2.67 |
| 2025-03-31 | $74k | 9.3k | 8.03 |